ReviewInternational ophthalmology2016
Ocular adnexal and orbital amyloidosis: a case series and literature review.
Review in International ophthalmology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Subepithelial Lesions of the Ocular Surface: A Review.Current ophthalmology reports · 2025Review
- Clinical analysis of 37 Chinese patients with ocular amyloidosis: a single center study.BMC ophthalmology · 2024Article
- Clinicopathologic and Proteomic Analysis of Amyloidomas Involving the Ocular Surface and Adnexa.American journal of clinical pathology · 2022Article
- Primary isolated amyloidosis in the extraocular muscle as a rare cause of ophthalmoplegia: A case report and literature review.American journal of ophthalmology case reports · 2021Article
- Orbital and adnexal amyloidosis: Thirty years experience at a tertiary eye care center.Indian journal of ophthalmology · 2021Article
- Rare Diseases of the Orbit.Laryngo- rhino- otologie · 2021Review
- Long-term follow-up of a case of amyloidosis-associated chorioretinopathy.American journal of ophthalmology case reports · 2020Article
- Intraocular amyloidosis with multifocal iris and anterior chamber translucent spherules.Indian journal of ophthalmology · 2019Article
- Yellow subconjunctival deposits.BMJ case reports · 2019Article
- [Slowly progressive upper eyelid swelling and ptosis].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019Article
- Long-Term Follow-Up of 4 Patients with Conjunctival Amyloidosis.Ocular oncology and pathology · 2018Article
- A Rare Case of Amyloidosis of the Eyelid and Conjunctiva.Case reports in ophthalmological medicine · 2016Article
- Lacrimal Gland Amyloidosis in an Elderly Patient.Case reports in ophthalmologyArticle
- Conjunctival Amyloidosis: A Report of Two Cases with Review of Literature - 2000-2020.Journal of microscopy and ultrastructureArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of the study was to describe the main clinical and epidemiologic characteristics, treatment options, and outcome in a large series of patients with periocular and orbital amyloidosis. This is a retrospective, descriptive, observational study of a case series of 14 patients with periocular and orbital amyloidosis and is a review of previously published cases with this diagnosis between September 2004 and January 2015. In this study, we analyzed our 14 patients in conjunction with 69 well-documented cases of orbital and/or periocular amyloidosis previously reported, with a total of 83. Of these, 54 were female (65.1 %), 28 male (33.7 %), and one with unspecified gender. The mean age at diagnosis was 54.9 years (range, 18-87). The localization of the amyloidosis was classified as superficial, deep and combined, with involvement of 53 (63.9 %), 26 (31.3 %), and four cases (4.8 %) in each group, respectively. The main findings in superficial amyloidosis were mass or tissue infiltration (84.9 %) and ptosis (30.2 %) and, in the cases with deep involvement, mass (65.4 %), proptosis (57.7 %), limited ocular movements (34.6 %), ocular displacement (30.8 %), and ptosis (26.9 %). The cases with combined involvement presented with signs and symptoms of the two groups. Regarding the outcome, 43 patients were reported stable after the diagnosis and 21 had recurrence or required new surgical procedures. Periocular and orbital amyloidosis is a rare disease that can present with a variety of symptoms and signs depending on the localization and extension of involvement. Its prompt recognition is important in order to investigate systemic disease, which will affect the prognosis of each case.
Indexed as
Identifiers
26466598What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.